Thoracic SMARCA4-deficient undifferentiated tumor: diagnostic characteristics, molecular insights, and treatment approaches
The Oncologist · 08.05.2025 · 30 (5)
DOI: 10.1093/oncolo/oyaf121 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Oncologist, online erschienen am 27.05.2025. Verfasst von Junmin Song und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY 10461, United States. Hauptthemen laut MEDLINE: DNA Helicases, Nuclear Proteins, Thoracic Neoplasms, Transcription Factors. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim, AstraZeneca, Merck.
Abstract (Originalsprache)
Thoracic SMARCA4-deficient undifferentiated tumor (SMARCA4-UT) is a newly defined disease entity characterized by aggressive clinical behavior, diagnostic complexity, and poor prognosis. Given its rarity and heterogeneous histological presentation, establishing a definitive diagnosis can be challenging and relies heavily on comprehensive molecular and immunohistochemical evaluation. Here, illustrating the challenges highlighted by a real-world case, we describe the diagnostic pathway leading to SMARCA4-UT identification and discuss the differential diagnosis of thoracic tumors, relevant molecular evaluations, the molecular basis of SMARCA4-UT, and treatment implications. Recognition of this recently described entity is crucial, as an accurate diagnosis—as demonstrated by our case—can guide effective therapy and facilitate enrollment in targeted clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY 10461, United States.
- Department of Pathology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, United States.
- Department of Hematology/Oncology, Columbia University, New York, NY 10032, United States.
- Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10461, United States.
ORCID-Profile: Junmin Song, Benjamin Herzberg, Balazs Halmos
Förderung
- Boehringer Ingelheim
- AstraZeneca
- Merck
- Bristol-Myers Squibb
- Advaxis
- Amgen
- AbbVie
- Daiichi Sankyo
Zitieren
APA
Song, J., Gersten, A., Herzberg, B., & Halmos, B. (2025). Thoracic SMARCA4-deficient undifferentiated tumor: diagnostic characteristics, molecular insights, and treatment approaches. The Oncologist, 30(5). https://doi.org/10.1093/oncolo/oyaf121
Vancouver
Song J, Gersten A, Herzberg B, Halmos B. Thoracic SMARCA4-deficient undifferentiated tumor: diagnostic characteristics, molecular insights, and treatment approaches. The Oncologist. 2025;30(5). doi:10.1093/oncolo/oyaf121
BibTeX
@article{Song2025,
author = {Song, Junmin and Gersten, Adam and Herzberg, Benjamin and Halmos, Balazs},
title = {Thoracic SMARCA4-deficient undifferentiated tumor: diagnostic characteristics, molecular insights, and treatment approaches},
journal = {The Oncologist},
year = {2025},
volume = {30},
number = {5},
doi = {10.1093/oncolo/oyaf121}
}
EUVIMED